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ABSTRACT
Objective To integrate information on cigarette
companies’ understanding and use of menthol as
summarised in published research based on previously
internal tobacco industry documents with results from
large population-based surveys of tobacco use and other
independent sources.
Data sources Papers published in this supplement of
Tobacco Control, together with papers identiﬁed using
PubMed searches.
Results Tobacco companies shaped consumer
perceptions of menthol cigarettes. Menthol is not just
a ﬂavouring agent. Cigarette companies use menthol’s
ability to mask irritation and provide sensory effects to
make menthol cigarettes appeal to youth and health-
concerned smokers, in part because menthol makes
low-tar cigarettes more palatable. Consistent with
targeted marketing, youths, women and African
Americans disproportionately smoke menthols. There
appear to be complex interactions with addictive effects
of nicotine. The ubiquitous addition of menthol by
tobacco companies to over 90% of all tobacco products,
whether labelled ‘menthol’ or not, demonstrates that
menthol is not simply a ﬂavour or brand. Menthol imparts
sensory characteristics to cigarettes and has a complex
interaction with nicotine that affects smoking behaviour
whether it is perceived or not, or whether cigarettes
containing menthol are marketed as ‘menthol’ or not.
Adding menthol increases ﬁne particles in cigarette
smoke, which have immediate adverse effects on the
risk of heart attack.
Conclusion Information from industry documents,
conﬁrmed by independent scientiﬁc literature,
consistently demonstrates that menthol increases
population harm from smoking by increasing initiation
and reducing cessation in some groups. Menthol
facilitates and increases smoking, which causes disease
and death.
On 22 June 2009, President Barack Obama signed
the Family Smoking Prevention and Tobacco
Control Act, giving the Food and Drug Adminis-
tration (FDA) authority to regulate tobacco prod-
ucts.
1 The law instructed the FDA to ban use of
candy, fruit and spice ﬂavours in cigarettes, but not
menthol. During the Congressional debate the
menthol exemption drew a strong response from
seven former Secretaries of Health and Human
Services and one Surgeon General who called it
discriminatory against African Americans and said
that the bill ‘cav(ed) to the ﬁnancial interests of
tobacco companies . (and sent) the message that
African American youngsters are valued less than
white youngsters’.
2 Owing to the public outcry
following the exclusion of menthol from the list of
banned additives, Congress amended the bill to
require that the FDA to prepare a study of menthol
by March 2011. This study could bedbut does not
have to bedthe ﬁrst step towards regulating or
eliminating menthol from cigarettes and other
tobacco products.
The ﬁrst menthol cigarette was created in 1925
by Lloyd ‘Spud’ Hughes who, while suffering from
a cold, stored menthol crystals along with his
tobacco and discovered the next day that he had
created a mentholated cigarette.
3 Since then, the
tobacco companies have known of menthol’s
ability to mask the harshness, increase the ease of
smoking and provide a cooling sensation that
appeals to many smokers
45Prior to 1956, sales of
menthol cigarettes represented about 3% of the
overall cigarette market in the USA,
6 reaching 20%
in 2006.
7 Menthol is added to over 90% of all
tobacco products whether labelled ‘menthol’ or
not.
8 (Internationally, tobacco companies
conﬁrmed in the 1990s that in Asia, menthol ciga-
rettes are important in attracting beginning
smokers and young people because of their prefer-
ences for lighter taste.
9) As the tobacco companies
recognised menthol’s value for recruiting and
retaining smokers, they conducted research to
reﬁne their marketing strategies and the cigarettes
themselves to improve their appeal.
We know these facts because, as a result of liti-
gation, we have access to over 60 million pages of
previously internal tobacco industry documents.
Indeed, in 2006, 3 years before Congress granted the
FDA authority to regulate tobacco products,
RJ Reynolds anticipated that the FDA would use
these documents to understand why and how the
industry makes and sells its products:
An industry has developed around the analysis of
Tobacco company documents (typically produced as
a part of litigation activities). This activity would
likely proceed since it is felt that it has
retrospectively demonstrated industry intentions
and provides a means to ensure industry activities
are kept in check. . The FDA would likely contract
with such groups to perform these tasks using
documents made available by the Industry.
10
As RJ Reynolds anticipated, many inves-
tigators,
4e6 91 1 e14 including several supported by
the FDA,
81 5 e19 have used the documents to
understand why and how the cigarette companies
use menthol to sell cigarettes.
This review compares the conclusions from
investigations into tobacco companies’ knowledge
about menthol with results from large population-
based surveys conducted by non-industry investiga-
tors. A remarkably consistent picture emerges,
which shows that consumer perceptions and use of
menthol cigarettes are largely consistent with the
companies’ planning. The information in the
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Research paperdocuments, however, goes beyond the information obtained from
independent population surveys to demonstrate that
mentholdeven at levels so low that they are not perceived by the
smokerdalso has important effects on smoking behaviour.
THE TOBACCO COMPANIES MANIPULATED MENTHOL
CONTENT AND MARKETING TO TARGET INITIATES AND YOUTH
Menthol cigarettes were not introduced to appeal to youth, but
by the mid-1970s industry market research began to reveal that
they were popular among young smokers because they were
perceived as less harsh and easier to smoke.
11 18 To capitalise on
these desirable characteristics, the companies manipulated
menthol levels and used targeted marketing to enhance the
menthol cigarettes’ appeal to this population.
18
A 1977 Philip Morris study found that the median age for
Lorillard Tobacco Company’s Newport King smokers was the
youngest for all cigarette brands: 24.8 years old compared with
38.0 for all smokers.
6 Newport’s success in the young adult
market demonstrated that mentholated cigarettes with rela-
tively low menthol content appealed disproportionately to
young people led other companies to develop low menthol
cigarettes. By the 1980s all major menthol brands had low
menthol varieties to target this market.
11 According to company
research in the 1980s, half of Newport smokers were under 25
and young smokers identiﬁed Newport as smoother, milder and
less harsh than Brown and Williamson’s Kool menthols, which
had higher levels of mentholation.
6
Tobacco companies developed marketing to target young
potential menthol smokers. Lorillard’s competitors attributed
Newport’s success to its appeal among younger smokers.
11 18 By
the 1990s Lorillard had built Newport into the most successful
menthol brand with its youthful and fun marketing campaign
that often depicted people doing childlike, silly activities.
6
Following Newport’s success, other menthol brands, including
RJ Reynolds’ Salem, copied the use of young people in their
marketing materials.
18
Independent research conﬁrms that menthol cigarette use is
more common among younger and newer teen smokers.
20e22
The 2004e2008 National Survey on Drug Use and Health
(NSDUH) shows the youngest current smokers in the study (age
12e17) had the highest past month menthol cigarette use.
22
Even though cigarette use declined between 2004 and 2008, the
fraction of smokers aged 12e17 years reporting past month
menthol use increased from 44% to 48%.
23 The NSDUH also
showed that smoking menthols was more likely for recent
initiates (started smoking within the past year) than for those
who started smoking more than a year earlier among those aged
12e17 (49% vs 44%) and 18e25 (40% vs 36%).
23 Studies focused
on youths have found smoking menthol cigarettes is signiﬁ-
cantly associated with indicators of nicotine dependency.
20 21
TOBACCO COMPANIES MANIPULATED MENTHOL CONTENT TO
REINFORCE SMOKING BEHAVIOUR AND ADDICTION
Industry documents consistently demonstrate that the compa-
nies manipulate menthol’s ability to mask the harshness,
increase the ease of smoking and provide a cooling sensation to
provide particular sensory effects.
5 12 13 16 17 They use menthol’s
sensory effects to minimise the immediate negative effects of
tobacco smoke (harshness, irritation) and superimpose positive
attributes (coolness, smoothness) to make menthol cigarettes
easier to inhale.
51 7These characteristics depend on the amount
of menthol added to cigarettes, with even non-identiﬁable levels
contributing to smoothness and a reduced harshness percei-
ved by smokers.
5 Beginning in the 1970s, tobacco companies
investigated the effects of adding different amounts of menthol
to cigarettes and manipulated menthol levels to develop
different cigarettes for young and experienced menthol
smokers.
12
In the early 1970s tobacco companies discovered that
increased menthol levels affected the ‘impact’ or the ‘grab’ that
smokers perceive in their throats when inhaling smoke that is
essential for the immediate perception of strength and satisfac-
tion.
5 16 A 1989 Philip Morris study concluded that impact
jointly depended on the levels of nicotine and menthol.
16
Furthermore, company research beginning in 1995 found that
menthol alone can increase impact, suggesting that menthol
reinforces smoking behaviour independent of nicotine.
24
Menthol’s nicotine-like effects led several companies to conclude
that menthol could be used to compensate for the reduced
‘satisfaction’ of low tar/nicotine yield cigarettes to increase their
appeal.
51 6Research done by Philip Morris in the 1980s even
suggested that a menthol-like additive could be used as an
analogue (substitute) for nicotine.
52 5Independent research
conﬁrmed different menthol levels in cigarettes depending on
company-deﬁned cigarette descriptors (eg, ultralight or light) or
cigarette length (eg, 100 mm or 85 mm).
26 These results are
consistent with tobacco company research suggesting that
menthol is used to offset reduced delivery or impact in low tar/
nicotine, ‘light’ cigarettes.
Independent research conﬁrms the companies’ understanding
that menthol’s particular anaesthetic and sensory characteristics
mask the immediate negative health effects of smoking
4 and its
potential interaction with nicotine.
24 Independent research
reported that menthol has analgesic, antitussive, antibacterial,
antiallergic and soothing effects on the respiratory tract, as well
as serving as an expectorate
4 and reinforcing the effects of
nicotine.
27 An independent study of smokers’ descriptions of
early experiences with cigarettes found differences in African
Americans’ and white people’s early smoking experiences, with
African Americans, who disproportionately started smoking
with menthols, reporting more positive and pleasurable experi-
ences as opposed to reporting dizziness or difﬁculty inhaling.
28
This work, combined with studies on the taste and rewarding
effects of smoking menthols, suggest that menthol reinforced
smoking, possibly leading to increased nicotine dependence.
27
Independent research conﬁrms the complex interaction
between menthol and nicotine that the cigarette companies
studied. Menthol smokers do not have signiﬁcantly different
Fagerström Test for Nicotine Dependence (FTND) scores than
non-menthol smokers.
27 29e31 Nevertheless, studies have
consistently found shorter time-to-ﬁrst-cigarette in menthol
smokers,
20 27 29e32 indicating higher levels of addiction.
However, menthol smokers also consistently report smoking
fewer cigarettes per day.
31 33 These two ﬁndings may help
explain the FTND results, because the FTND depends on both
time-to-ﬁrst cigarette and number of cigarettes per day. These
consistent but seemingly contradictory results suggest that
there is a complex interaction between menthol and nicotine in
terms of the cigarettes’ addictive properties.
TOBACCO COMPANY MARKETING ASSOCIATES MENTHOL
CIGARETTES WITH MEDICINAL PROPERTIES AND IMPLIED
HEALTH MESSAGES
Early menthol cigarette brands (Spud, Kool) were introduced as
a remedy for throat irritation, cough, allergies or heavy
smoking.
6 8 After menthol cigarettes were introduced in the
1920s tobacco companies’ menthol cigarette advertising
ii2 Tobacco Control 2011;20(Suppl 2):ii1eii7. doi:10.1136/tc.2011.043604
Research paperemphasised health beneﬁts
8 and connected them with medicinal
remedies that commonly contain menthol, such as chest rubs
and throat lozenges.
68Until the 1950s most menthol cigarettes
were only smoked occasionally by smokers.
6 This pattern was
consistent with explicit health messages that presented menthol
cigarettes as a healthier alternative to non-menthols to be used
when smokers felt they temporarily needed a less harsh cigarette
to relieve symptoms.
6 A 1951 case report in the Journal of the
American Medical Association reﬂected this widely accepted health
messaging by referring to menthol cigarettes as ‘medicated
cigarettes’, which the reporting physician observed that patients
used for their ‘anesthetic and cooling effect . for rhinitis,
pharyngitis, laryngitis, and bronchitis’.
34
The public was becoming more worried about the dangers of
cigarette smoke in 1952 when Reader’s Digest printed an article
entitled ‘Cancer by the Carton’.
35 By the mid-1950s the cigarette
companies had stopped making explicit health claims in their
advertising because they believed that such messaging reminded
people of the association between smoking and cancer.
6 During
the 1980s, however, the companies continued to appreciate the
continuing beneﬁts of the association between menthol ciga-
rettes and health established before the mid-1950s.
8
After the public became more aware of, and concerned about
smoking’s health dangers menthol cigarette marketing shifted to
more subtle health reassurance messages emphasising the posi-
tive experience of smoking menthols.
6 8 By describing menthol
cigarettes as ‘clean’, ‘fresh’, ‘refreshing’ and ‘cool’, tobacco
marketing put the focus on the taste of menthols as a positive
feature while still suggesting health beneﬁts to reassure
smokers.
8 In the 1970s, British American Tobacco and its US
subsidiary Brown and Williamson, described marketing goals for
brand promotion to ‘convince smokers . that Kent menthol is
the menthol that offers refreshing menthol smoking satisfaction
and health reassurance’
36 and to position the Kool menthol
brand into the ‘health reassurance segment’.
15 37 After this shift
to reassurance rather than explicit health claims, tobacco
companies continued to recognise the importance of retaining
a connection between menthol and health in the general public.
For example, Brown and Williamson developed a 1979e1985
prime marketing objective for Kool menthol cigarettes to provide
reassurance with the message that Kool cigarettes are ‘safe’
through the launch of a ‘low-tar’ or ‘mild’ product.
83 7
Tobacco company research in the 1960s and 1970s consistently
found that smokers perceive menthol cigarettes as healthier,
safer, milder and less harmful.
8 38 This effect seems to have faded
with time. Independent research using the 2009 HealthStyles
survey
39 and the 2005 New Jersey Adult Tobacco Survey
40
showed few menthol smokers or respondents overall (smokers
and non-smokers) believed that menthol cigarettes were less
harmful than non-menthol cigarettes. Both studies also show
younger respondents are more likely than older ones to report
that menthol cigarettes are more harmful/risky.
39 40 This age
effect also appeared in a 2010 study using focus group and survey
data to assess attitudes and beliefs about menthol cigarettes
among African Americans: beliefs that menthol cigarettes have
medicinal effects and are less harmful were most likely to be held
by older smokers.
41 These results may reﬂect the fact that older
smokerswere more likelyto have been exposedto earlier industry
advertisements promoting menthol’s health ‘beneﬁts’.
THE TOBACCO COMPANIES TARGETED VULNERABLE GROUPS
FOR MENTHOL CIGARETTE PROMOTIONS
In addition to youth, the cigarette companies targeted women
and African Americans for menthol cigarettes.
6 8 Independent
research in the open literature conﬁrms that smokers in these
populations are more likely to smoke menthol cigarettes than
others.
674 2
Women
Women were the ﬁrst group targeted by tobacco companies for
menthol use. By the 1950s most menthol smokers were
women.
6 After RJ Reynolds introduced Salem menthols in 1956,
tobacco companies noted that female smokers liked the new
ﬁlters, longer cigarettes and menthol ﬂavour.
6 Menthol cigarette
advertising at the time used images of romance, beauty, nature,
relaxation and female desirability to appeal to women.
6 Tobacco
companies disproportionately advertised menthols in women’s
magazines and on daytime television. For example, Brown and
Williamson’s 1969 Kool campaign to promote its extra-long
menthol cigarettes was named ‘Lady Be Kool’ based on knowl-
edge that female menthol smokers preferred extra-long ciga-
rettes.
6 Beginning in the 1980s and early 1990s, companies
expanded targeted marketing of menthols to women in Japan,
Korea and Singapore where menthol sales subsequently rose
rapidly and brands have attracted high proportions of young
women.
89
Conﬁrming conclusions from tobacco industry documents,
independent research demonstrates higher proportions of
women continue to smoke menthol than non-menthol ciga-
rettes. The higher prevalence of menthol smoking among
women is conﬁrmed by nationally representative surveys.
According to the 2004e2008 National Survey on Drug Use and
Health (NSDUH), over 52% of menthol smokers are female
compared with 43% for non-menthol.
22 23 The 2003 and 2006e7
Tobacco Use Supplements to the Current Population Survey
(TUS-CPS) show higher prevalence of menthol smoking among
women aged 18+ with 55% of menthol smokers being female
compared with 44% for non-menthol.
7 The 2005 National
Health Interview Survey and Cancer Control Supplement show
that women are signiﬁcantly more likely to be menthol smokers
(25% for white people, 78% for black people and 36% for
Hispanic people) than men (15% for white people, 70% for black
people and 17% for Hispanic people) after adjusting for age,
income and education.
42 This pattern appears internationally.
For example, survey data from Japan show that, by 2000, 48% of
female high-school smokers smoked menthols compared with
18% of males.
9
African Americans
Before the 1960s, African Americans smoked menthol and
non-menthol cigarettes at rates similar to the general popula-
tion, and like the general population, most smoked non-menthol
brands.
6 In the following decades, tobacco companies competed
for menthol market share and targeted inner cities predomi-
nantly composed of African American residents with menthol
cigarette marketing during the late 1970se1990s.
43 The 2003
and 2006e7 TUS-CPS indicated that 74% of adult African
American smokers smoked menthol cigarettes compared with
21% of non-Hispanic white people.
7 This dramatic change in the
proportion of African American menthol smokers coincided
with cigarette company target marketing of menthol cigarettes
to African Americans beginning in the 1960s.
44
Tobacco companies used a variety of marketing methods to
reach the African American market to increase sales,
8 14 43 44
including concentrating menthol cigarette advertisements in
popular African American magazines and television
programmes.
84 4Tobacco companies found that African Ameri-
cans were more likely than white people to trust advertising and
Tobacco Control 2011;20(Suppl 2):ii1eii7. doi:10.1136/tc.2011.043604 ii3
Research paperpromotional campaigns targeted at them.
44 Company research
found that in the 1960s and 1970s African Americans were more
likely to believe health messaging related to menthol
44 4and
respond favourably to menthol marketing efforts to associate
menthol cigarettes with African American culture.
64 4Tobacco
companies reinforced conventional advertising campaigns in
several ways. Tobacco companies formed organisational and
philanthropic relationships with black community groups and
civil rights organisations,
45 developed tailored brands in the
1990s (such as RJ Reynolds’ Uptown and an independent Boston
ﬁrm’sX
44 46) and targeted black urban neighbourhoods by
distributing free menthol cigarettes using mobile vans in the
1980s and early 1990s, as well as using retailer incentive
programmes.
14 43
The independent literature conﬁrms that these targeted
marketing and public relations efforts were successful. The
2004e2008 National Survey on Drug Use and Health (NSDUH)
indicated that 83% of African Americans aged 12 or older
reported smoking menthol cigarettes in the past month
compared with 24% of white people.
23
Independent research on the receptivity of African Americans
to tobacco industry health messaging on menthol has tended to
ﬁnd that African Americans are more likely to associate menthol
cigarettes with reduced health risk, although research is mixed.
Focus group and survey data collected in 2006 among African
Americans in Los Angeles, California, show that African Amer-
ican menthol smokers had signiﬁcantly higher measures of
positive attitudes and beliefs regarding the medicinal effects and
reduced harm of menthol cigarettes than non-menthol smokers
by 10% and 9%, respectively.
41 Another study using data from
the 2009 HealthStyles survey of US households found that
African Americans are signiﬁcantly more likely to believe that
menthol cigarettes have health beneﬁts compared to white
people (OR¼3.2, 95% CI 1.8 to 5.7).
39 Similar ﬁndings have been
published using interview data from African American smokers
in Atlanta, Georgia, during 2005 showing that participants
believed that smoking menthols leads to fewer negative health
effects than smoking non-menthols.
47 In contrast, one study
using the 2005 New Jersey Adult Tobacco Survey found that
African Americans overall were no more likely than other groups
to believe that menthols are less risky than non-menthols and
that current African American smokers were more likely to
believe that menthols are more risky.
40
TOBACCO COMPANIES MANIPULATED MENTHOL CONTENT
AND MARKETING TO DECREASE DESIRE TO QUIT AND INHIBIT
CESSATION
The tobacco documents show that the companies used and
manipulated sensory characteristics of menthol cigarettes and
health messaging in advertising to reassure smokers that
menthol cigarettes were safer than non-menthols to assuage
smokers’ health concerns
6 81 5and probably contributed to
decreased motivation of some smokers to quit.
12 15 Tobacco
company research also identiﬁed declining social acceptability of
smoking, particularly smokers’ concern about how their
secondhand smoke is perceived by and affects non-smokers,
48 49
as one motivation for quitting that could be addressed by
menthol’s masking of tobacco odour.
15
Health concerns have been repeatedly shown to be the
primary reason that smokers quit, so masking irritation and
immediate negative health effects of smoking potentially
prevents cessation by providing a false sense of wellbeing and
obscuring the health effects of smoking.
4 15 The health
messaging that tobacco companies used to associate menthol
cigarettes with medicinal properties,
68manipulation of the
soothing/cooling sensory effects of menthol that make them
easier to inhale
51 7and easier for new and young smokers to
smoke
11 18 all probably contributed to the perception among
some smokers that menthol cigarettes are healthier than non-
menthol cigarettes and that menthols are a partial solution to
the negative health effects of smoking.
12 15
After the attention to the health effects of smoking that
began in the 1950s, tobacco companies increased efforts to
manufacture and market low-tar and low-nicotine cigarette
brands.
15 In the 1970s, company research showed that menthol
cigarettes were considered by some to be a more ﬂavourful, and
yet mild, alternative to new non-menthol low-tar cigarettes,
12
and the companies attributed the coincident growth of menthol
brands like RJ Reynolds’ Salem and Lorillard’s Newport to this
perception.
15 Tobacco company studies found that many
menthol smokers switched from non-menthols after smoking
menthols when experiencing a cold when the harshness of
non-menthol cigarettes was too irritating to their throats.
81 21 5
Tobacco company research on brand switching in the 1970s
found that menthol cigarettes experienced a 13% gain in market
share as a result of switching to menthol brands from high
ﬁltration brands, compared with 8% for high ﬁltration brands as
a result of switching from menthol brands, showing that more
smokers were switching to menthols than from them.
15
Company focus group studies found that some menthol
smokers had switched to menthols as an alternative to quitting,
leading some company researchers in the 1960s through the
1980s to conclude that because menthol cigarettes were
perceived as having less irritation and increased safety, they
could be positioned as an alternative to quitting.
81 5In 1979,
a report for Philip Morris supported this conclusion by ﬁnding
that fewer menthol smokers report wanting to quit (39%) than
non-menthol smokers (43%).
8
In the 1990s, tobacco companies also found that smokers were
facing increased concern about secondhand smoke
48 49 and that
menthol cigarettes reduced the perception of offensive tobacco
odour associated with smokers, thereby making smokers feel that
smoking menthol cigarettes was more socially acceptable than
non-menthol cigarettes both inside
15 and outside
9 the USA. This
ﬁnding inspired a 1990 RJ Reynolds marketing strategy for its
menthol brand Horizon that explicitly advertised an ‘improved
lingering aroma’.
15 50 Like other efforts to develop socially
acceptable cigarettes,
48 this idea was ultimately abandoned
because it called attention to the negative perception of smoke
odour.
15 In addition, because menthol masks some of the char-
acteristicsofsmoking, menthol cigarettesmaybeassociated with
the denial of personal identiﬁcation as a ‘smoker’,
12 which would
mitigate conﬂict related to the social unacceptability of smoking.
There are conﬂicting ﬁndings in the open literature on the
effects of menthol on cessation and relapse, likely due to the use
of different outcomes, measures, and types of studies, with more
evidence indicating lower quit rates and higher relapse rates
among menthol smokers.
27 51 A study of current smokers using
the 2003 and 2006e7 TUS-CPS to assess cessation of menthol
smoking found no signiﬁcant relation between menthol and
non-menthol cigarettes and quit attempts in the past year or
length of smoking abstinence.
31 However, other studies using
the same 2003 and 2006e7 TUS-CPS showed that those who
used to regularly smoke menthol cigarettes compared with
non-menthol were less likely to quit.
51 52 One
52 found that
menthol smokers were less likely to have quit for at least
6 months across racial groups (African Americans OR¼0.23;
Asian American/Paciﬁc Islander OR¼0.22; Hispanic OR¼0.49;
ii4 Tobacco Control 2011;20(Suppl 2):ii1eii7. doi:10.1136/tc.2011.043604
Research paperNative American OR¼0.49; non-Hispanic white OR¼0.28).
Another
51 similarly found that menthol smokers are signiﬁcantly
less likely to have successfully quit than non-menthol smokers
in the past year and in the past 5 years (adjusted OR¼0.97 and
OR¼0.94, respectively). These different results may be because
the ﬁrst study
31 was of current daily smokers while the second
52
and third
51 were of former smokers (smoked at least 100 ciga-
rettes but did not smoke at the time of survey). Limiting the
sample to current daily smokers may obscure differences in
cessation success because it excludes smokers who were able to
become non-daily users in attempts to quit. Without more
speciﬁc information about successful quitting and smoking
patterns among menthol smokers and non-menthol smokers it is
difﬁcult to assess this possibility. However, tobacco company
studies identiﬁed a possible relation between menthol cigarettes
and social smoking, suggesting that social smoking among
menthol users was associated with someone who is not a ‘real
smoker’ or who is trying to give up smoking.
12
Research on menthol and cessation has consistently found
that the association between menthol cigarette smoking and
difﬁculty quitting is stronger among racial/ethnic minority
groups, younger smokers and in studies done after 1999.
53 The
2005 National Health Interview Study Cancer Control Supple-
ment shows signiﬁcant interaction effects between being
African American and menthol use (interaction term adjusted
OR¼0.72) in predicting population quit ratio (the total number
of former smokers divided by the total number of individuals
who had reported smoking in their lifetime).
54 This result
indicates that being African American and smoking menthol
makes someone less likely to quit than just the additive effects
of being African American and smoking menthols. The 2003 and
2006e7 TUS-CPS also showed that among African Americans
(adjusted OR¼1.62) and Hispanics (adjusted OR¼1.21) smoking
menthol cigarettes was signiﬁcantly associated with seriously
considering quitting and a positive estimation of successfully
quitting (African American OR¼1.87 and Hispanic OR¼1.34).
52
However, former menthol smokers in both groups were signiﬁ-
cantly less likely to have successfully quit compared with non-
menthol smokers for at least 6 months (African American
OR¼0.23 and Hispanic OR¼0.48), suggesting that for African
Americans and Hispanics menthol cigarettes may increase
smokers’ perception of the ease of quitting while, at the same
time, undermining their success rates.
52
THE CIGARETTE COMPANIES AVOIDED CONDUCTING
RESEARCH ON THE DISEASE-INDUCING EFFECTS OF MENTHOL,
BUT DID FIND ADVERSE EFFECTS ON THE AMOUNT OF FINE
PARTICLES IN THE SMOKE OF MENTHOLATED CIGARETTES
Studies of tobacco industry documents did not locate much
company research on the direct toxic effects of menthol.
19
Instead, the companies concentrated on monitoring the
(limited) independent research in this area and used it in internal
and external brieﬁng papers to argue that there were no direct
adverse health effects of menthol.
19 We only located two
epidemiological studies of the association of smoking menthol
cigarettes with disease, one on atherosclerosis and pulmonary
function
55 and one on oesophageal cancer,
56 both of which
reported no difference between smokers of menthol and
non-menthol cigarettes. (The study of oesophageal cancer
56 was
from an individual with funding from the tobacco industry.
57)
These limited ﬁndings do not mean, however, that adding
menthol to cigarettes does not have any direct negative health
effects. Research conducted by the cigarette companies,
19 some
of which was published in the open literature,
58e61 consistently
demonstrated that adding menthol to cigarettes increased the
number of ﬁne particles in the smoke by 10e20%. Even at the
low levels found in outdoor air pollution or secondhand smoke,
which are much lower levels than delivered in active smoking,
these ﬁne particles have a direct adverse effect on cardiovascular
morbidity and mortality and can trigger an acute cardiac
event.
62e66
CONCLUSION
The results of both internal tobacco company research and
studies done in the independent scientiﬁc literature are
remarkably consistent in showing that menthol inﬂuences much
more than the taste of cigarette smoke. In addition to its candy-
like appeal, menthol’s sensory effects and ability to mask irri-
tation make menthol cigarettes appealing as a likely starter
product. Youths disproportionately smoke menthols, in part
because of these sensory characteristics and targeted marketing.
Menthol marketing has also been targeted at groups (youths,
women and African Americans) that have disproportionate
percentages of menthol smokers. Menthol’s sensory qualities
may also make low-tar cigarettes more palatable and make it
easier for inexperienced smokers to progress into increased
exposure and, thus, reinforce dependence on nicotine.
Menthol’s use for promoting cigarette smoking goes beyond
its use as a ﬂavouring, highlighted by the point that tobacco
companies knew as early as 1972 that menthol enhances the
perception of smoothness even at unidentiﬁable levels and in
non-menthol cigarettes. The ubiquitous addition of menthol by
tobacco companies to over 90% of all tobacco products, whether
labelled ‘menthol’ or not, demonstrates that menthol is not
simply a ﬂavour or brand. Menthol imparts sensory character-
istics to cigarettes and has a complex interaction with nicotine
that affects smoking behaviour whether it is perceived or not, or
whether cigarettes containing menthol are marketed as
‘menthol’ or not.
The consistency between industry marketing efforts and
population use patterns of menthol cigarettes contradicts the
conclusions in a 2010 review by a tobacco company scientist
that research examining menthol’s effects on smoking behaviour
‘is not possible from survey data’ because of ‘social, demographic
and peer inﬂuence mediators and confounders’.
67
Menthol facilitates and increases smoking, which causes
disease and death. In developing regulations for tobacco prod-
ucts, the law directs the FDA to consider (i) the risks and
beneﬁts to the population as a whole; . (ii) the increased or
decreased likelihood that existing users of tobacco products will
stop using such products; and (iii) the increased or decreased
What this paper adds
< Tobacco companies have manipulated marketing and the
content of menthol cigarettes to increase smoking and
discourage cessation.
< Tobacco companies’ knowledge and use of menthol
in cigarettes are supported by ﬁndings in the open
literature. Cigarette companies use the fact that menthol
makes cigarettes easier to smoke to encourage initiation,
reinforce addiction and complicate cessation. In addition,
tobacco companies’ marketing efforts associate menthol with
health and targets vulnerable groups such as youths, women
and African Americans.
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Research paperlikelihood that those who do not use tobacco products will start
using such products.
1 The information in the industry docu-
ments, conﬁrmed in the independent scientiﬁc literature,
consistently demonstrates that menthol increases the popula-
tion harm due to smoking because it increases initiation and
reduces cessation in some groups. There also appear to be
complex interactions with the addictive effects of nicotine. In
addition, there is evidence suggesting that adding menthol
increases harm by increasing ﬁne particles in cigarette smoke,
which have immediate adverse effects on the risk of a heart
attack. Based on this large and consistent body of evidence,
public health demands that the FDA and similar agencies
outside the US ban all use of menthol, in not only cigarettes but
also similar products such as cigars, cigarillos, and menthol
sprays which are used with roll-your-own tobacco products,
regardless of whether the menthol is used a characterizing taste
or present at levels below sensory detection. These agencies
should also recognize that menthol is used in smokeless prod-
ucts and likely has similar interactions with nicotine and ban
such use until presented with compelling evidence that
including menthol in these products is not producing similar
harm as it does in smoked tobacco products.
Funding This research was funded by NCI grants CA-113710 and CA-87472. The
funding agency played no role in the selection of topic, conduct of the research or
preparation of the manuscript.
Competing interests None.
Contributors Both authors worked together to draft the manuscript.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1. Family Smoking Prevention and Tobacco Control Act P.L. 111e31, 123 Stat. 1776. 2009.
2. Califano J, Sullivan LW, Shalala DE, et al. Letter to Representatives and Senators re:
the Family Smoking Prevention and Tobacco control Act. of Document. 2008. Source.
http://www.nytimes.com/2008/06/05/business/05TobaccoLetter.html?
_r¼1&ref¼business (Estimated).
3. Reid JR. A History of Mentholated Cigarettes ‘This Spud’s for You’: Philip Morris,
1993. http://legacy.library.ucsf.edu/tid/nqf32e00.
4. Garten S, Falkner RV. Continual smoking of mentholated cigarettes may mask the
early warning symptoms of respiratory disease. Prev Med 2003;37:291e6.
5. Ferris Wayne G, Connolly GN. Application, function, and effects of menthol in
cigarettes: a survey of tobacco industry documents. Nicotine Tob Res 2004;6(Suppl
1):S43e54.
6. Sutton CD, Robinson RG. The marketing of menthol cigarettes in the United States:
populations, messages, and channels. Nicotine Tob Res 2004;6(Suppl 1):S83e91.
7. Lawrence D, Rose A, Fagan P, et al. National patterns and correlates of mentholated
cigarette use in the United States. Addiction 2010;105(Suppl 1):13e31.
8. Anderson SJ. Marketing of menthol cigarettes and consumer perceptions: a review
of tobacco industry documents. Tobacco Control 2011;20(Suppl 2):ii20eii28.
9. Connolly GN, Behm I, Osaki Y, et al. The impact of menthol cigarettes on smoking
initiation among non-smoking young females in Japan. Int J Environ Res Public Health
2011;8:1e14.
10. Smith LB. FDA Regulation of the Tobacco Industry: RJ Reynolds, December 6. http://
legacy.library.ucsf.edu/tid/jot81b00.
11. Kreslake JM, Wayne GF, Alpert HR, et al. Tobacco industry control of menthol in
cigarettes and targeting of adolescents and young adults. Am J Public Health
2008;98:1685e92.
12. Kreslake JM, Wayne GF, Connolly GN. The menthol smoker: tobacco industry
research on consumer sensory perception of menthol cigarettes and its role in
smoking behavior. Nicotine Tob Res 2008;10:705e15.
13. Kreslake JM, Yerger VB. Tobacco industry knowledge of the role of menthol in
chemosensory perception of tobacco smoke. Nicotine Tob Res 2010;12(Suppl 2):
S98e101.
14. Cruz TB, Wright LT, Crawford G. The menthol marketing mix: targeted promotions
for focus communities in the United States. Nicotine Tob Res 2010;12(Suppl 2):
S147e53.
15. Anderson SJ. Menthol cigarettes and smoking cessation behavior: a review of
tobacco industry documents. Tobacco Control 2011;20(Suppl 2):ii49eii56.
16. Yerger VB. Menthol’s potential effects on nicotine dependence: a tobacco industry
perspective. Tobacco Control 2011;20(Suppl 2):ii29eii36.
17. Yerger VB, McCandless PM. Menthol sensory qualities and smoking topography:
a review of the tobacco industry documents. Tobacco Control 2011;20(Suppl 2):
ii37eii43.
18. Klausner K. Menthol cigarettes and smoking initiation: a tobacco industry
perspective. Tobacco Control 2011;20(Suppl 2):ii12eii19.
19. Salgado VM, Glantz SA. Direct disease-inducing effects of menthol through the
eyes of tobacco companies. Tobacco Control 2011;20(Suppl 2):ii44eii48.
20. Hersey JC, Ng SW, Nonnemaker JM, et al. Are menthol cigarettes a starter product
for youth? Nicotine Tob Res 2006;8:403e13.
21. Hersey JC, Nonnemaker JM, Homsi G. Menthol cigarettes contribute to the appeal
and addiction potential of smoking for youth. Nicotine Tob Res 2010;12(Suppl 2):
S136e46.
22. Rock VJ, Davis SP, Thorne SL, et al. Menthol cigarette use among racial and ethnic
groups in the United States, 2004e2008. Nicotine Tob Res 2010;12(Suppl 2):S117e24.
23. Anon. Substance Abuse and Mental Health Services Administration, Ofﬁce of Applied
Studies. Rockville, MD: The NSDUH Report: Use of Menthol Cigarettes, 2009.
24. Ahijevych K, Garrett BE. Menthol pharmacology and its potential impact on
cigarette smoking behavior. Nicotine Tob Res 2004;6(Suppl 1):S17e28.
25. Gullotta FP. A Menthol Analogue for Low Delivery Non-Menthol Cigarettes: Philip
Morris, May 9. http://legacy.library.ucsf.edu/tid/vio46b00.
26. Celebucki CC, Wayne GF, Connolly GN, et al. Characterization of measured menthol
in 48 U.S. cigarette sub-brands. Nicotine Tob Res 2005;7:523e31.
27. Ahijevych K, Garrett BE. The role of menthol in cigarettes as a reinforcer of smoking
behavior. Nicotine Tob Res 2010;12(Suppl 2):S110e16.
28. Finkenauer R, Pomerleau CS, Snedecor SM, et al. Race differences in factors
relating to smoking initiation. Addict Behav 2009;34:1056e9.
29. Muscat JE, Chen G, Knipe A, et al. Effects of menthol on tobacco smoke exposure,
nicotine dependence, and NNAL glucuronidation. Cancer Epidemiol Biomarkers Prev
2009;18:35e41.
30. Okuyemi KS, Ahluwalia JS, Ebersole-Robinson M, et al. Does menthol attenuate
the effect of bupropion among African American smokers? Addiction
2003;98:1387e93.
31. Fagan P, Moolchan ET, Hart A Jr, et al. Nicotine dependence and quitting behaviors
among menthol and non-menthol smokers with similar consumptive patterns.
Addiction 2010;105(Suppl 1):55e74.
32. Wackowski O, Delnevo CD. Menthol cigarettes and indicators of tobacco
dependence among adolescents. Addict Behav 2007;32:1964e9.
33. Mendiondo MS, Alexander LA, Crawford T. Health proﬁle differences for menthol
and non-menthol smokers: ﬁndings from the National Health Interview Survey.
Addiction 2010;105(Suppl 1):124e40.
34. Highstein B, Zeligman I. Nonthrombocytopenic purpura caused by mentholated
cigarettes. J Am Med Assoc 1951;146:816.
35. Glantz SA. The Cigarette Papers. Berkeley: University of California Press, 1996.
36. Lorillard. Kent Menthol 1009s: Lorillard. http://legacy.library.ucsf.edu/tid/
dud20e00.
37. Lorillard. Kool Family Utopian Objectives 1979e1985. Research. http://legacy.
library.ucsf.edu/tid/xjm66b00.
38. Giovino GA, Sidney S, Gfroerer JC, et al. Epidemiology of menthol cigarette use.
Nicotine Tob Res 2004;6(Suppl 1):S67e81.
39. Davis SP, McClave-Regan AK, Rock VJ, et al. Perceptions of menthol cigarette use
among U.S. adults and adult smokers: ﬁndings from the 2009 HealthStyles survey.
Nicotine Tob Res 2010;12(Suppl 2):S125e35.
40. Wackowski OA, Delnevo CD, Lewis MJ. Risk perceptions of menthol cigarettes
compared with nonmenthol cigarettes among New Jersey adults. Nicotine Tob Res
2010;12:786e90.
41. Allen B Jr, Cruz TB, Leonard E, et al. Development and validation of a scale to
assess attitudes and beliefs about menthol cigarettes among african american
smokers. Eval Health Prof 2010;33:414e36.
42. Cubbin C, Soobader MJ, LeClere FB. The intersection of gender and race/ethnicity in
smoking behaviors among menthol and non-menthol smokers in the United States.
Addiction 2010;105(Suppl 1):32e8.
43. Yerger VB, Przewoznik J, Malone RE. Racialized geography, corporate activity, and
health disparities: tobacco industry targeting of inner cities. J Health Care Poor
Underserved 2007;18(4 Suppl):10e38.
44. Gardiner PS. The African Americanization of menthol cigarette use in the United
States. Nicotine Tob Res 2004;6(Suppl 1):S55e65.
45. Yerger VB, Malone RE. African American leadership groups: smoking with the
enemy. Tob Control 2002;11:336e45.
46. Balbach ED, Gasior RJ, Barbeau EM. R.J. Reynolds’ targeting of African Americans:
1988e2000. Am J Public Health 2003;93:822e7.
47. Richter P, Beistle D, Pederson L, et al. Small-group discussions on menthol
cigarettes: listening to adult African American smokers in Atlanta, Georgia. Ethn
Health 2008;13:171e82.
48. Ling PM, Glantz SA. Tobacco industry consumer research on socially acceptable
cigarettes. Tob Control 2005;14:e3.
49. Schane RE, Glantz SA, Ling PM. Social smoking implications for public health,
clinical practice, and intervention research. Am J Prev Med 2009;37:124e31.
50. Young Rubicam. Horizon Strategic Marketing Review: RJ Reynolds, October 1.
http://legacylibraryucsfedu/tid/yzt03a00.
51. Levy D, Blackman K, Tauras JA, et al. Quit attempts and quit rates among menthol
and non-menthol smokers: ﬁndings from a national population survey. Am J Public
Health. In press.
52. Trinidad DR, Perez-Stable EJ, Messer K, et al. Menthol cigarettes and smoking
cessation among racial/ethnic groups in the United States. Addiction 2010;105(Suppl
1):84e94.
ii6 Tobacco Control 2011;20(Suppl 2):ii1eii7. doi:10.1136/tc.2011.043604
Research paper53. Foulds J, Hooper MW, Pletcher MJ, et al. Do smokers of menthol cigarettes ﬁnd it
harder to quit smoking? Nicotine Tob Res 2010;12(Suppl 2):S102e9.
54. Stahre M, Okuyemi KS, Joseph AM, et al. Racial/ethnic differences in menthol
cigarette smoking, population quit ratios and utilization of evidence-based tobacco
cessation treatments. Addiction 2010;105(Suppl 1):75e83.
55. Pletcher MJ, Hulley BJ, Houston T, et al. Menthol cigarettes, smoking cessation,
atherosclerosis, and pulmonary function: the Coronary Artery Risk Development in
Young Adults (CARDIA) Study. Arch Intern Med 2006;166:1915e22.
56. Hebert JR, Kabat GC. Menthol cigarette smoking and oesophageal cancer. Int J
Epidemiol 1989;18:37e44.
57. Bero LA, Glantz S, Hong MK. The limits of competing interest disclosures. Tob
Control 2005;14:118e26.
58. Carmines EL. Evaluation of the potential effects of ingredients added to cigarettes.
Part 1: cigarette design, testing approach, and review of results. Food Chem Toxicol
2002;40:77e91.
59. Baker RR, Massey ED, Smith G. An overview of the effects of tobacco
ingredients on smoke chemistry and toxicity. Food Chem Toxicol 2004;42
(Suppl):S53e83.
60. Baker RR, Pereira da Silva JR, Smith G. The effect of tobacco ingredients on smoke
chemistry. Part II: casing ingredients. Food Chem Toxicol 2004;42(Suppl):
S39e52.
61. Rustemeier K, Stabbert R, Haussmann HJ, et al. Evaluation of the potential effects
of ingredients added to cigarettes. Part 2: chemical compositino of mainstream
smoke. Food Chem Toxicol 2002;40:93e104.
62. Brook RD, Franklin B, Cascio W, et al. Air pollution and cardiovascular disease:
a statement for healthcare professionals from the Expert Panel on Population and
Prevention Science of the American Heart Association. Circulation 2004;109:2655e71.
63. Pope CA 3rd, Burnett RT, Thurston GD, et al. Cardiovascular mortality and long-term
exposure to particulate air pollution: epidemiological evidence of general
pathophysiological pathways of disease. Circulation 2004;109:71e7.
64. Pope CA 3rd, Burnett RT, Krewski D, et al. Cardiovascular mortality and exposure to
airborne ﬁne particulate matter and cigarette smoke: shape of the exposure-response
relationship. Circulation 2009;120:941e8.
65. Brook RD, Rajagopalan S, Pope CA 3rd, et al. Particulate matter air pollution and
cardiovascular disease: an update to the scientiﬁc statement from the American
Heart Association. Circulation 2010;121:2331e78.
66. Institute of Medicine Committee on Secondhand Smoke Exposure and
Acute Coronary Events. Secondhand Smoke Exposure and Cardiovascular
Effects: Making Sense of the Evidence. Washington, DC: National Academies Press,
2010.
67. Heck JD. A review and assessment of menthol employed as a cigarette ﬂavoring
ingredient. Food Chem Toxicol 2010;48(Suppl 2):S1e38.
Tobacco Control 2011;20(Suppl 2):ii1eii7. doi:10.1136/tc.2011.043604 ii7
Research paper